Repurposing of FDA-approved drugs as novel therapeutics for COVID-19

Wu, Jian Hui | $478,000

Quebec CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General 2020 CIHR Operating Grant

Currently, there is no vaccine or effective therapeutics for COVID-19, which is caused by 2019-nCoV (now officially referred to as SARS-CoV-2). Tens of thousands of people get infected by SARS-CoV-2 and substantial percentage of them showed severe symptoms. Dr Wu’s team proposed to rapidly screen database of FDA-approved drugs by computationally approaches and further evaluate the top-ranking candidates by an array of experimental assays. This project could rapidly lead to drug candidates for COVID-19.

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback